Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
By J. Gerich. Diabetic Medicine, 2010
616 citations recorded by the source corpus.
Diabet. Med. 27, 136–142 (2010)
Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5dc37e39565ba10e1d42d186584c2c76994ae198
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Molecular Biology
Citations in the corpus
- Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials (2017, background): “Furthermore, as SGLT2 inhibitors have a unique mechanism of action that does not depend on a functioning pancreatic -cell, they have several potential advantages over other classes of glucose-lowering agents in the treatment of T2DM [5, 7].”